References
- Atlas E, Turck M. Laboratory and clinical evaluation of rifampicin. Am J Med Sci 1968: 256(4): 47–54
- Scheuer PJ, Summerfield JA, Lal S, et al. Rifampicin hepatitis: a clinical and histological study. Lancet 1974: 1(855): 421–5
- Yu VL, Zuravleff JJ, Peacock JE, et al. Addition of rifampin to carboxypenicillin-amino-glycoside combination for the treatment of Pseudomonas aeruginosa infection: clinical experience with four patients. Antimicrob Agents Chemother 1984: 26: 575–7
- Nessi R, Fowst G. Clinical use of rifampicin in combination for non-mycobacterial infections: a survey of published evidence. J Int Med Res 1979: 7(3): 179–86
- Meningococcal disease: secondary attack rate and chemoprophylaxis in the United States, 1974. JAMA 1976: 235(3): 261–5